Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efaproxiral plus oxygen with whole brain radiation vs oxygen with whole brain radiation in brain metastases from breast cancer
2004-002109-58Phase 3Completed
- Sponsor
- Allos Therapeutics
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of efaproxiral in breast cancer (2 arms), sponsored by Allos Therapeutics. Primary endpoint: Overall survival. Started Jan 2005; status: completed.
02
Drugs
efaproxiral
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-002109-58.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002109-58.